International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Latest Content
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Exousia Pro Orphan Drug Designation in Glioma
2
What to Know About the FDA Approval of Blenrep for Multiple Myeloma
3
Sharing Insights Into a Multiple Myeloma Journey
4
With Cancer, 'Your Outlook Will be Significant in Beating this Disease'
5
